TRAW compared with PRLD: revenue, margins and what each company keeps, and the suppliers and customers both name

TRAWTraws Pharma, Inc.

Mkt capRevenueRevenue

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

Compare

TRAWTraws Pharma, Inc.

PRLDPrelude Therapeutics Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TRAWTraws Pharma, Inc.

0.30▼−1.23%· post 0.30

Mkt cap$4.5MRevenue$3MQ2 FY25Revenue$3MFY24

PRLDPrelude Therapeutics Inc

3.89▼−5.01%· post 3.89

ClosedOct 30 '26

Mkt cap$309.6MRevenue$6MQ2 FY26Revenue—

Compare

ClosedOct 30 '26

TRAWTraws Pharma, Inc.

PRLDPrelude Therapeutics Inc

0.30▼−1.23%post 0.30

Price

3.89▼−5.01%post 3.89

$4.5M

Mkt cap

$309.6M

Q2 FY25$3M

Revenue

$6MQ2 FY26

FY24$3M

Revenue

—

TRAW0.30▼−1.23%vsPRLD3.89▼−5.01%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

TRAW, solidPRLD, dashed

Supply-chain overlap

Revenue flow

TRAW: latest quarter is a loss; flow not drawable. PRLD: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TRAW 3

—Temple Universityunlistedsupplier

—Viriomunlistedsupplier

—HanX Biopharmaceuticalsunlistedcustomer

Shared 0

No shared counterparties.

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR